![](https://www.biocognon.com/wp-content/uploads/2024/04/back-of-card-scaled.jpg)
Biocognon
Molecular recognition technology for better antibodies
A Nanobody discovery platform to transform the discovery and development of antibody-based therapeutics and diagnostics.
![](https://www.biocognon.com/wp-content/uploads/2024/03/CSG-website-NB-target-4-panel-1200-DPI-scaled.jpg)
Biocognon’s Nanobody discovery platform is based on patented fluorogen activating proteins that report specific binding between a yeast surface displayed Nanobody and a target antigen secreted from the same cell.